Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00124644 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Withdrawn due to "toxicity" problems

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: etoposide
DRUG: tipifarnib
PROCEDURE: chemotherapy
PROCEDURE: enzyme inhibitor therapy
PROCEDURE: high-dose chemotherapy

Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

[object Object]